Diagnostic Criteria for Acute Pancreatitis
Acute pancreatitis is diagnosed when at least 2 of 3 criteria are met: (1) abdominal pain consistent with pancreatitis (typically radiating to the back), (2) serum lipase or amylase ≥3 times the upper limit of normal, and (3) characteristic findings on contrast-enhanced CT or MRI. 1, 2, 3
Laboratory Diagnosis
Serum lipase is the preferred first-line diagnostic test over amylase due to superior sensitivity (91% vs 62%), higher specificity for pancreatic tissue, and longer elevation duration (8-14 days vs 3-7 days). 1, 2, 4 The diagnostic threshold is ≥3 times the upper limit of normal, which provides optimal balance between sensitivity and specificity. 1, 2, 4
Critical Caveat
The degree of enzyme elevation does NOT correlate with disease severity—patients can have severe pancreatitis with only modest enzyme elevations. 2, 4 Do not be falsely reassured by mildly elevated enzymes.
Initial Workup (Within 48 Hours)
Complete the diagnostic evaluation within 48 hours of admission to avoid missing alternative life-threatening intra-abdominal catastrophes. 1, 2, 4
Required initial laboratory tests: 2, 4
- Serum lipase
- Liver chemistries (AST, ALT, bilirubin, alkaline phosphatase) - early elevation suggests gallstone etiology 5
- Serum triglycerides (levels >1000 mg/dL definitively indicate hypertriglyceridemia-induced pancreatitis) 2, 4
- Serum calcium 2, 4
- Complete blood count and metabolic panel 3
Required initial imaging:
- Abdominal ultrasound at admission in ALL patients to detect gallstones, bile duct dilation, and free peritoneal fluid 1, 2, 4
- Chest and abdominal plain x-rays to exclude other pathology 4
Severity Stratification (Within 48 Hours)
Use the APACHE II scoring system with a cutoff of 8 to predict severe disease. 5, 2, 4 This should be performed in all patients within 48 hours. 5
Additional severity markers:
- C-reactive protein >150 mg/L at 48 hours is the best available laboratory marker for severity assessment 2, 4
- Procalcitonin is the most sensitive test for detecting pancreatic infection; low values strongly predict absence of infected necrosis 4
- Persistent organ failure (cardiovascular, respiratory, or renal) for >48 hours indicates severe acute pancreatitis with mortality exceeding 50% 5
Key Distinction
Patients with organ failure that resolves within 48 hours have 0% mortality, while those with persistent organ failure >48 hours have >50% mortality. 5 This 48-hour threshold is critical for risk stratification.
Imaging Strategy for Severity Assessment
Avoid routine early CT scanning within 72 hours of symptom onset—it underestimates pancreatic necrosis and rarely changes initial management. 1, 4
Perform contrast-enhanced (dynamic) CT after 72-96 hours in patients with: 5, 1, 2, 4
- APACHE II score >8
- Predicted severe disease by clinical scoring
- Evidence of organ failure during initial 72 hours
- Diagnostic uncertainty
The CT should assess degree of pancreatic necrosis and peripancreatic fluid collections, which more reliably predict subsequent infected necrosis or complications requiring intervention. 5
Etiologic Investigation
For gallstone pancreatitis:
- Early ultrasound is essential; repeat if initially negative 5
- At least two good quality ultrasound examinations are necessary before accepting "idiopathic" diagnosis 5
- Early increase in serum aminotransferases or bilirubin suggests gallstone etiology 5
For idiopathic pancreatitis (after negative initial workup):
- Endoscopic ultrasound (EUS) is the preferred test, performed 2-6 weeks after resolution, uncovering etiology in 29-88% of patients 1, 4
- MRCP is a reasonable alternative when EUS expertise unavailable (97.98% sensitivity, 84.4% specificity for choledocholithiasis) 1
- For patients >40 years with unexplained pancreatitis, perform CT or EUS to exclude pancreatic malignancy, even after a single episode 1, 4, 6
Additional etiologic testing: 5
- Detailed alcohol intake history (units per week)
- Fasting lipid panel (after acute phase)
- Drug history review
- Viral exposure assessment if clinically indicated
Treatment Criteria
Patients with predicted severe disease or persistent organ failure should be admitted to ICU whenever possible. 5
Patients with infected necrosis and persistent organ failure have the highest risk of death. 5 These patients require multidisciplinary management including endoscopists, interventional radiologists, and surgeons. 7